Skip to content
Healthcare Industry Regulatory & Strategic Advisory

Healthcare Industry Regulatory & Strategic Advisory

End-to-End Compliance, Market Access & Regulatory Intelligence for Healthcare Enterprises

The global healthcare industry is undergoing rapid transformation driven by evolving regulatory frameworks, technological innovation, and heightened compliance expectations. In such a highly regulated ecosystem, ensuring regulatory compliance, product approval, and seamless market access is not optional—it is a critical business requirement.

At ELT Corporate, we provide premium healthcare regulatory advisory services designed to support medical device manufacturers, pharmaceutical companies, biotechnology enterprises, diagnostics firms, and healthcare startups in achieving full regulatory alignment across India and international markets.

We combine deep regulatory expertise, scientific understanding, and strategic consulting to enable faster approvals, reduced compliance risk, and accelerated commercialization.

Strategic Healthcare Advisory Expertise

Strategic Healthcare Advisory Expertise

We go beyond compliance—we enable regulatory strategy, product positioning, and market entry planning.

01

Medical Device Regulatory Intelligence & CDSCO Compliance (India)

We offer comprehensive advisory under the Medical Device Rules, 2017, covering the entire product lifecycle:

  • Medical Device Classification (Risk-based Class A, B, C, D)
  • CDSCO Import License (MD-15, MD-14)
  • Manufacturing License (MD-5, MD-9)
  • Device Master File (DMF) & Plant Master File (PMF)
  • Essential Principles Checklist (EPC) Mapping
  • Clinical Evaluation Report (CER) Preparation (EU MDR aligned)
  • Risk Management File (ISO 14971)
  • Biocompatibility & Performance Study Strategy
  • Product Testing & Laboratory Coordination (ISO/IEC 17025 labs)
  • Regulatory Query Response & Endorsement Handling
We ensure zero-rejection submission readiness with audit-compliant documentation.
CDSCOMedical device lifecycle readiness
02

Pharmaceutical Regulatory & Drug Approval Advisory

We support pharmaceutical and life science companies with:

  • Drug Manufacturing & Import Licenses
  • Form 40 / Form 41 / Form 42 Applications
  • CDSCO Central & State Licensing Strategy
  • WHO-GMP & GMP Certification Advisory
  • Stability Studies & Technical Documentation
  • Labeling Compliance as per Drugs & Cosmetics Rules
  • Regulatory Inspection Preparation
  • Import Clearance & Customs Documentation
Our expertise ensures regulatory acceptance across Indian and export markets.
GMPDrug approval documentation support
03

Biotechnology, Biologics & Advanced Therapies Advisory

We assist biotech innovators and life science companies in navigating complex regulatory pathways:

  • Regulatory Classification of Biotech Products
  • Biosafety & Bioethics Compliance Strategy
  • Clinical Trial Regulatory Support
  • R&D Documentation for Regulatory Submission
  • Market Authorization Strategy for Biologics
  • Export Compliance for Advanced Therapies
  • Global Regulatory Mapping (India, EU, US FDA)
We bridge the gap between scientific innovation and regulatory approval.
BiologicsScience-led regulatory pathway planning
04

FSSAI Compliance for Nutraceuticals & Healthcare Foods

We provide complete compliance solutions for food-based healthcare products:

  • FSSAI Central & Import Licensing
  • Ingredient & Additive Regulatory Validation
  • Permissible Limit Assessment (FSSAI Standards)
  • Label Review & Nutrition Panel Compliance
  • Health Claims Validation & Risk Review
  • Import Clearance Documentation
  • Product Categorization (Nutraceutical / Food / Supplement)
We ensure your product is regulator-ready and market-safe before launch.
FSSAIHealthcare food compliance before launch
05

BIS Certification & Quality Conformity Advisory

We assist manufacturers in achieving BIS compliance under applicable Indian Standards:

  • ISI Mark Certification Advisory
  • Scheme X Compliance (Medical Devices & Critical Products)
  • Product Testing Coordination with BIS-recognized Labs
  • Factory Audit Preparation & Documentation Support
  • Quality Management System Alignment (ISO 13485 integration)
  • Technical File Review for Certification Readiness
We ensure smooth certification with minimal regulatory friction.
BISCertification and quality conformity
06

Clinical, Technical & Scientific Documentation Excellence

We provide globally aligned documentation support:

  • Clinical Evaluation Reports (CER – MDR/EU MDR aligned)
  • Technical Files & Device Dossiers
  • Risk Management Files (ISO 14971 compliant)
  • Predicate Device Mapping & Justification
  • Scientific Literature Review & Evidence Compilation
  • Regulatory Gap Analysis Reports
Our documentation is designed for global regulatory acceptance and audit readiness.
EvidenceAudit-ready technical documentation
07

Global Healthcare Market Access Strategy

We enable companies to expand beyond India with structured regulatory planning:

  • EU MDR Regulatory Strategy & CE Marking Support
  • US FDA Regulatory Pathway Guidance (510(k), De Novo)
  • Middle East (SFDA, MOH) Compliance Strategy
  • ASEAN Regulatory Approvals
  • Export Documentation & Free Sale Certificate Support
  • International Product Positioning Strategy
We transform regulatory compliance into global business expansion opportunities.
GlobalInternational market access strategy
Why Leading Healthcare Companies Trust ELT Corporate

Why Leading Healthcare Companies Trust ELT Corporate

✔ Deep specialization in CDSCO, BIS, FSSAI & global healthcare regulations
✔ Strong experience across 1000+ regulatory dossiers
✔ High approval success rate with reduced query cycles
✔ Cross-functional expertise (legal + technical + clinical + regulatory)
✔ End-to-end submission, tracking & authority coordination
✔ Strategic advisory beyond compliance
Industries We Serve

Industries We Serve

We provide regulatory advisory across the entire healthcare ecosystem:

Regulatory advisory across the entire healthcare ecosystem. Sector-specific support for companies preparing documentation, approvals, market entry and compliance operations.
01
Medical Device Manufacturers (Class A–D)CDSCO
02
Diagnostic & Imaging Equipment CompaniesDevices
03
Pharmaceutical & API ManufacturersDrugs
04
Biotechnology & Biologics FirmsBiotech
05
Hospital & Healthcare Infrastructure ProvidersHealthcare
06
Nutraceutical & Functional Food BrandsFSSAI
07
Importers & Global DistributorsMarket
Our Regulatory Execution Framework

Our Regulatory Execution Framework

We follow a structured 4-phase compliance execution model:

Phase 1: Regulatory Mapping

Identify applicable laws, classification, and approval pathway

Phase 2: Technical Gap Analysis

Evaluate product readiness vs regulatory requirements

Phase 3: Documentation & Dossier Development

Prepare complete submission-ready regulatory package

Phase 4: Authority Submission & Approval Management

Handle queries, follow-ups, and final approval closure

Frequently Asked Questions

Frequently Asked Questions (FAQs)

1. What is healthcare regulatory advisory?

Healthcare regulatory advisory involves guidance and support for compliance with government regulations related to medical devices, pharmaceuticals, biotechnology, and food products. It ensures products meet safety, quality, and legal requirements before market entry.

2. What services are included in CDSCO medical device approval?

CDSCO approval services include medical device classification, MD-5/MD-15 licensing, Device Master File (DMF), Plant Master File (PMF), Clinical Evaluation Report (CER), risk management documentation, and query handling support.

3. Do I need BIS certification for medical devices in India?

Yes, certain medical devices require BIS certification under applicable Indian Standards or Scheme X. It ensures product quality, safety, and compliance with national regulations.

4. What is FSSAI compliance for healthcare products?

FSSAI compliance ensures that nutraceuticals, dietary supplements, and food-based healthcare products meet safety standards, permitted ingredient limits, labeling rules, and licensing requirements.

5. What is a Clinical Evaluation Report (CER)?

A CER is a technical document that evaluates clinical safety and performance of a medical device based on scientific literature, clinical data, and risk analysis. It is mandatory for regulatory approval in many markets.